Jan 12 |
Microbot Medical files to sell 1.77M shares for its holders
|
Jan 3 |
Microbot Medical (MBOT) Announces Positive GLP Study Results
|
Dec 29 |
Microbot Medical down 22%, exercises investment options for $2.73M proceeds
|
Dec 29 |
Microbot Medical Announces Exercise of Outstanding Preferred Investment Options for $2.73 Million in Gross Proceeds Priced At-the-Market Under Nasdaq Rules
|
Dec 28 |
Gold Moves Lower; US Crude Stocks Decline Last Week
|
Dec 28 |
Microbot to advance Liberty Robotic System into pivotal clinical trial
|
Dec 28 |
Microbot Medical Announced Positive Results of Its GLP Pivotal Pre-Clinical Study Where All Study Objectives Were Met
|
Dec 14 |
Microbot Medical and Corewell Health Forge Collaboration to Establish the LIBERTY® Endovascular Robotic Surgical System for Telerobotic
|
Dec 7 |
Microbot Medical Announces the Successful Completion of Its GLP Pivotal Pre-Clinical Study, a Critical Milestone for Its IDE submission to Commence Human Clinical Study
|
Nov 21 |
Microbot Medical Appoints Seasoned Medical Expert Dr. Juan Diaz- Cartelle as its New Chief Medical Officer in Anticipation of Its Clinical, Regulatory and Commercial Activities
|